Paramètres de radiorésistance des cancers des voies aérodigestives supérieures et stratégies de radiosensibilisation

This publication has 101 references indexed in Scilit:

• Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial
  The Lancet Oncology, 2012
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site
  Radiotherapy and Oncology, 2011
• Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
  New England Journal of Medicine, 2010
• High expression of excision repair cross-complementation group1 protein predicts poor outcome in patients with nasopharyngeal cancer
  Oral Oncology, 2010
• Hypoxia inducible factors in cancer stem cells
  British Journal of Cancer, 2010
• Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
  The Lancet Oncology, 2010
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
  Radiotherapy and Oncology, 2009
• Evaluating Erythropoietin-Associated Tumor Progression Using Archival Tissues from a Phase III Clinical Trial
  Stem Cells, 2009
• PET Imaging of Hypoxia
  PET Clinics, 2009
• Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia
  JAMA, 2008